<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35031121</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5883</ISSN><JournalIssue CitedMedium="Internet"><Volume>438</Volume><PubDate><Year>2022</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of the neurological sciences</Title><ISOAbbreviation>J Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19.</ArticleTitle><Pagination><StartPage>120146</StartPage><MedlinePgn>120146</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jns.2022.120146</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-510X(22)00005-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Persistent cognitive symptoms have been reported following COVID-19 hospitalization. We investigated the relationship between demographics, social determinants of health (SDOH) and cognitive outcomes 6-months after hospitalization for COVID-19.</AbstractText><AbstractText Label="METHODS">We analyzed 6-month follow-up data collected from a multi-center, prospective study of hospitalized COVID-19 patients. Demographic and SDOH variables (age, race/ethnicity, education, employment, health insurance status, median income, primary language, living arrangements, and pre-COVID disability) were compared between patients with normal versus abnormal telephone Montreal Cognitive Assessments (t-MOCA; scores&lt;18/22). Multivariable logistic regression models were constructed to evaluate predictors of t-MoCA.</AbstractText><AbstractText Label="RESULTS">Of 382 patients available for 6-month follow-up, 215 (56%) completed the t-MoCA (n&#xa0;=&#xa0;109/215 [51%] had normal and n&#xa0;=&#xa0;106/215 [49%] abnormal results). 14/215 (7%) patients had a prior history of dementia/cognitive impairment. Significant univariate predictors of abnormal t-MoCA included older age, &#x2264;12&#xa0;years of education, unemployment pre-COVID, Black race, and a pre-COVID history of cognitive impairment (all p&#xa0;&lt;&#xa0;0.05). In multivariable analyses, education &#x2264;12&#xa0;years (adjusted OR 5.21, 95%CI 2.25-12.09), Black race (aOR 5.54, 95%CI 2.25-13.66), and the interaction of baseline functional status and unemployment prior to hospitalization (aOR 3.98, 95%CI 1.23-12.92) were significantly associated with abnormal t-MoCA scores after adjusting for age, history of dementia, language, neurological complications, income and discharge disposition.</AbstractText><AbstractText Label="CONCLUSIONS">Fewer years of education, Black race and unemployment with baseline disability were associated with abnormal t-MoCA scores 6-months post-hospitalization for COVID-19. These associations may be due to undiagnosed baseline cognitive dysfunction, implicit biases of the t-MoCA, other unmeasured SDOH or biological effects of SARS-CoV-2.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valdes</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charvet</LastName><ForeName>Leigh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Ariane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thawani</LastName><ForeName>Sujata</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balcer</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galetta</LastName><ForeName>Steven L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wisniewski</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frontera</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Neurology, New York University Grossman School of Medicine, New York, NY, USA. Electronic address: jennifer.frontera@nyulangone.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG060882</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066512</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Neurol Sci</MedlineTA><NlmUniqueID>0375403</NlmUniqueID><ISSNLinking>0022-510X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064890" MajorTopicYN="N">Social Determinants of Health</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain fog</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Cognitive</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Long-hauler</Keyword><Keyword MajorTopicYN="N">MOCA</Keyword><Keyword MajorTopicYN="N">Memory</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35031121</ArticleId><ArticleId IdType="pmc">PMC8739793</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2022.120146</ArticleId><ArticleId IdType="pii">S0022-510X(22)00005-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alemanno F., Houdayer E., Parma A., et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M., Cejudo J.C., Sotoca J., Deus J., Krupinski J. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav. Immun. Health. 2020;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Amalakanti S., Arepalli K.V.R., Jillella J.P. Cognitive assessment in asymptomatic COVID-19 subjects. Virusdisease. 2021:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883942</ArticleId><ArticleId IdType="pubmed">33614860</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaud V., Crottaz-Herbette S., Dunet V., et al. Pattern of cognitive deficits in severe COVID-19. J. Neurol. Neurosurg. Psychiatry. 2021;92:567&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053331</ArticleId><ArticleId IdType="pubmed">33219042</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O.H., Wu S., Mera R.M., Costa A.F., Recalde B.Y., Issa N.P. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort. Eur. J. Neurol. 2021;28(10):3245&#x2013;3253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Groiss S.J., Balloff C., Elben S., et al. Prolonged neuropsychological deficits, central nervous system involvement, and brain stem affection after COVID-19-a case series. Front. Neurol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674620</ArticleId><ArticleId IdType="pubmed">33224088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J., Barnett T.A., Asken B.M., et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neuro-Oncol. 2021;27:191&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp J.A., Dressing A., Blazhenets G., et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini F., Ferrario I., Mazziotti D., et al. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation. Arch. Phys. Med. Rehabil. 2021;102:155&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521874</ArticleId><ArticleId IdType="pubmed">32991870</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside D.M., Oleynick V., Holker E., Waldron E.J., Porter J., Kasprzak M. Neurocognitive deficits in severe COVID-19 infection: case series and proposed model. Clin. Neuropsychol. 2021:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">33487098</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., Pottgen J., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2 (fcaa205)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P., Ferrazzoli D., Sebastianelli L., et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: insights into a challenging symptom. J. Neurol. Sci. 2021;420</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834526</ArticleId><ArticleId IdType="pubmed">33359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 2021;426 doi: 10.1016/j.jns.2021.117486. Epub 2021 May 12. PMID: 34000678; PMCID: PMC8113108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J. Neurol. Sci. 2021;426</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Melmed K., Fang T., et al. Toxic metabolic encephalopathy in hospitalized patients with COVID-19. Neurocrit. Care. 2021;35(3):693&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962078</ArticleId><ArticleId IdType="pubmed">33725290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling M.R., Ringel J.B., Pinheiro L.C., et al. Social determinants of health and 90-day mortality after hospitalization for heart failure in the REGARDS study. J. Am. Heart Assoc. 2020;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428585</ArticleId><ArticleId IdType="pubmed">32316807</ArticleId></ArticleIdList></Reference><Reference><Citation>Penman-Aguilar A., Talih M., Huang D., Moonesinghe R., Bouye K., Beckles G. Measurement of health disparities, health inequities, and social determinants of health to support the advancement of health equity. J. Public Health Manag. Pract. 2016;22(Suppl. 1):S33&#x2013;S42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845853</ArticleId><ArticleId IdType="pubmed">26599027</ArticleId></ArticleIdList></Reference><Reference><Citation>Majoka M.A., Schimming C. Effect of social determinants of health on cognition and risk of Alzheimer disease and related dementias. Clin. Ther. 2021;43(6):922&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pubmed">34103175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhang Y., Sholle E., et al. Assessing the impact of social determinants of health on predictive models for potentially avoidable 30-day readmission or death. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316307</ArticleId><ArticleId IdType="pubmed">32584879</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Lewis A., Melmed K., et al. Prevalence and predictors of prolonged cognitive and psychological symptoms following COVID-19 in the United States. Front. Aging Neurosci. 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8326803</ArticleId><ArticleId IdType="pubmed">34349633</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzano A., Scarinci A., Monda V., et al. The social brain and emotional contagion: COVID-19 effects. Medicina (Kaunas) 2020;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7760735</ArticleId><ArticleId IdType="pubmed">33255569</ArticleId></ArticleIdList></Reference><Reference><Citation>Price-Haywood E.G., Burton J., Fort D., Seoane L. Hospitalization and mortality among black patients and white patients with Covid-19. N. Engl. J. Med. 2020;382:2534&#x2013;2543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269015</ArticleId><ArticleId IdType="pubmed">32459916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogedegbe G., Ravenell J., Adhikari S., et al. Assessment of racial/ethnic disparities in hospitalization and mortality in patients with COVID-19 in new York City. JAMA Netw. Open. 2020;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7718605</ArticleId><ArticleId IdType="pubmed">33275153</ArticleId></ArticleIdList></Reference><Reference><Citation>Upshaw T.L., Brown C., Smith R., Perri M., Ziegler C., Pinto A.D. Social determinants of COVID-19 incidence and outcomes: a rapid review. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011781</ArticleId><ArticleId IdType="pubmed">33788848</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Sabadia S., Lalchan R., et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in new York City. Neurology. 2021;96:e575&#x2013;e586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunkel A.R., Glaser C.A., Bloch K.C., et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2008;47:303&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">18582201</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 2004;39:1267&#x2013;1284.</Citation><ArticleIdList><ArticleId IdType="pubmed">15494903</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan A., Tunkel A.R., Bloch K.C., et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin. Infect. Dis. 2013;57:1114&#x2013;1128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3783060</ArticleId><ArticleId IdType="pubmed">23861361</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunkel A.R., Hasbun R., Bhimraj A., et al. 2017 Infectious Diseases Society of America&#x2019;s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin. Infect. Dis. 2017;64:e34&#x2013;e65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5848239</ArticleId><ArticleId IdType="pubmed">28203777</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott T.F., Frohman E.M., De Seze J., et al. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the therapeutics and technology assessment Subcommittee of the American Academy of neurology. Neurology. 2011;77:2128&#x2013;2134.</Citation><ArticleIdList><ArticleId IdType="pubmed">22156988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco R.L., Kasner S.E., Broderick J.P., et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064&#x2013;2089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11078537</ArticleId><ArticleId IdType="pubmed">23652265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokke C., van den Berg B., Drenthen J., Walgaard C., van Doorn P.A., Jacobs B.C. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 2014;137:33&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">24163275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalita J., Misra U.K., Das M. Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry. 2008;79:289&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">17615164</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar J.J., Kohl K.S., Gidudu J., et al. Guillain-Barre syndrome and fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">20600491</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J., Mainali S., Fink E.L., et al. Global consortium study of neurological dysfunction in COVID-19 (GCS-NeuroCOVID): study design and rationale. Neurocrit. Care. 2020;33:25&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243953</ArticleId><ArticleId IdType="pubmed">32445105</ArticleId></ArticleIdList></Reference><Reference><Citation>van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">3363593</ArticleId></ArticleIdList></Reference><Reference><Citation>York CCfCoN Median Incomes [online] 2021. https://data.cccnewyork.org/data/table/66/median-incomes#66/107/62/a/a Available at: Accessed Septebmer 2021.</Citation></Reference><Reference><Citation>Blum A.B., Egorova N.N., Sosunov E.A., et al. Impact of socioeconomic status measures on hospital profiling in new York City. Circ. Cardiovasc. Qual. Outcomes. 2014;7:391&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4072036</ArticleId><ArticleId IdType="pubmed">24823956</ArticleId></ArticleIdList></Reference><Reference><Citation>UnitedStatesZipCodes.org Household Income [online] 2021. https://www.unitedstateszipcodes.org/11550/ Available at. Accessed Septebmer 2021.</Citation></Reference><Reference><Citation>Pendlebury S.T., Welch S.J., Cuthbertson F.C., Mariz J., Mehta Z., Rothwell P.M. Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal cognitive assessment versus face-to-face Montreal cognitive assessment and neuropsychological battery. Stroke. 2013;44:227&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5593099</ArticleId><ArticleId IdType="pubmed">23138443</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., Bedirian V., et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti H.C., Lacritz L.H., Cullum C.M., Weiner M.F. Normative data for the Montreal cognitive assessment (MoCA) in a population-based sample. Neurology. 2011;77:1272&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">21917776</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D., Lai J.S., Nowinski C.J., et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012;78:1860&#x2013;1867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3369516</ArticleId><ArticleId IdType="pubmed">22573626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira F.L., Bota D.P., Bross A., Melot C., Vincent J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754&#x2013;1758.</Citation><ArticleIdList><ArticleId IdType="pubmed">11594901</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., de Mendonca A., Cantraine F., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on &#x201c;sepsis-related problems&#x201d; of the European Society of Intensive Care Medicine. Crit. Care Med. 1998;26:1793&#x2013;1800.</Citation><ArticleIdList><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb Hooper M., Napoles A.M., Perez-Stable E.J. COVID-19 and racial/ethnic disparities. JAMA. 2020;323:2466&#x2013;2467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9310097</ArticleId><ArticleId IdType="pubmed">32391864</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani S.A., Marsiske M., Cottler L.B., Chen X., Striley C.W. Optimal cutoffs for the Montreal cognitive assessment vary by race and ethnicity. Alzheimers Dement. (Amst.) 2018;10:773&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6247398</ArticleId><ArticleId IdType="pubmed">30505927</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz M.J., Wang C., Nester C.O., et al. T-MoCA: a valid phone screen for cognitive impairment in diverse community samples. Alzheimers Dement. (Amst.) 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864219</ArticleId><ArticleId IdType="pubmed">33598528</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani S.A., Marsiske M., Striley C.W. Discriminative ability of Montreal cognitive assessment subtests and items in racial and ethnic minority groups. Alzheimer Dis. Assoc. Disord. 2019;33:226&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6710139</ArticleId><ArticleId IdType="pubmed">31058685</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricke-Galindo I., Falfan-Valencia R. Genetics insight for COVID-19 susceptibility and severity: a review. Front. Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047200</ArticleId><ArticleId IdType="pubmed">33868239</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips N., Park I.W., Robinson J.R., Jones H.P. The perfect storm: COVID-19 health disparities in US blacks. J. Racial Ethn. Health Disparities. 2021;8(5):1153&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510013</ArticleId><ArticleId IdType="pubmed">32965660</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh U., Hernandez K.M., Aronow B.J., Wurtele E.S. African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures. Sci. Rep. 2021;11:9905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110974</ArticleId><ArticleId IdType="pubmed">33972602</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscatelli F., Sessa F., Valenzano A., et al. COVID-19: role of nutrition and supplementation. Nutrients. 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8002713</ArticleId><ArticleId IdType="pubmed">33803015</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeda E.R., Glymour M.M., Quesenberry C.P., Whitmer R.A. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement. 2016;12:216&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969071</ArticleId><ArticleId IdType="pubmed">26874595</ArticleId></ArticleIdList></Reference><Reference><Citation>Weuve J., Barnes L.L., Mendes de Leon C.F., et al. Cognitive aging in black and white Americans: cognition, cognitive decline, and incidence of Alzheimer disease dementia. Epidemiology. 2018;29:151&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5718953</ArticleId><ArticleId IdType="pubmed">28863046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenehan M.E., Summers M.J., Saunders N.L., Summers J.J., Vickers J.C. Relationship between education and age-related cognitive decline: a review of recent research. Psychogeriatrics. 2015;15:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">25516261</ArticleId></ArticleIdList></Reference><Reference><Citation>NYC DoE School Quality Reports and Resources [online] 2021. https://infohub.nyced.org/reports/school-quality/school-quality-reports-and-resources Available at. (Accessed 7/26), Accessed Septebmer 2021.</Citation></Reference><Reference><Citation>Lambert N. Indiana University School of Medicine; Indianapolis, IN: 2020. COVID 19 "Long Hauler" Symptoms Survey Report.</Citation></Reference><Reference><Citation>Raman R., Rajalakshmi R., Surya J., et al. Impact on health and provision of healthcare services during the COVID-19 lockdown in India: a multicentre cross-sectional study. BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7817386</ArticleId><ArticleId IdType="pubmed">33468529</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Lu S., Chen J., et al. The landscape of cognitive function in recovered COVID-19 patients. J. Psychiatr. Res. 2020;129:98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam Hampshire W.T., Chamberlain Samuel R., Jolly Amy, Grant Jon E., Patrick Fiona, Mazibuko Ndaba, Williams Steve, Barnby Joseph M., Hellyer Peter, Mehta Mitul A. Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N=84,285 online study. MedRxiv. 2021;39:101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown S.M., Collingridge D.S., Wilson E.L., et al. Preliminary validation of the Montreal cognitive assessment tool among sepsis survivors: a prospective pilot study. Ann. Am. Thorac. Soc. 2018;15:1108&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">30168744</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen R.C., Lopez O., Armstrong M.J., et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology. Neurology. 2018;90:126&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5772157</ArticleId><ArticleId IdType="pubmed">29282327</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Flier W.M., Scheltens P. Epidemiology and risk factors of dementia. J. Neurol. Neurosurg. Psychiatry. 2005;76(Suppl. 5):v2&#x2013;v7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1765715</ArticleId><ArticleId IdType="pubmed">16291918</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel J.I. Racial/ethnic and gender disparities in health care use and access. Health Serv. Res. 2018;53:1407&#x2013;1429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5980371</ArticleId><ArticleId IdType="pubmed">28480588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook B.L., Trinh N.H., Li Z., Hou S.S., Progovac A.M. Trends in racial-ethnic disparities in access to mental health care, 2004-2012. Psychiatr. Serv. 2017;68:9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5895177</ArticleId><ArticleId IdType="pubmed">27476805</ArticleId></ArticleIdList></Reference><Reference><Citation>Gary F.A. Stigma: barrier to mental health care among ethnic minorities. Issues Ment. Health Nurs. 2005;26:979&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pubmed">16283995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>